Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Kamilla Winther has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12707996

ANTAGONISTIC DR3 LIGANDS

IPC classification:
A61K 39/395, A61P 37/00, C07K 14/705, C07K 16/28
Applicant:
Novo Nordisk A/S
Agent:
Kamilla Winther, Novo Nordisk A/S
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature